Log in to save to my catalogue

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cell...

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1990443128

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells

About this item

Full title

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells

Publisher

Athens: Spandidos Publications UK Ltd

Journal title

International journal of oncology, 2018-02, Vol.52 (2), p.621-629

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications UK Ltd

More information

Scope and Contents

Contents

N6-methyladenosine (m6A) is the most abundant epitranscriptome modification in mammalian mRNA. Recent years have seen substantial progress in m6A epitranscriptomics, indicating its crucial roles in the initiation and progression of cancer through regulation of RNA stabilities, mRNA splicing, microRNA processing and mRNA translation. However, by wha...

Alternative Titles

Full title

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1990443128

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1990443128

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2017.4219

How to access this item